Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Nuclear receptor subfamily 4 group A member 1 (NR4A1, NGFI-B, NURR77)

March 5, 2015 8:00 AM UTC

Mouse studies suggest NR4A1 agonists could help treat multiple types of fibrosis. In a mouse model of transforming growth factor (TGF)-β-driven skin fibrosis, NR4A1 knockout increased expression of pr...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article